10-Q 1 fy1617q3jfm10-qreport.htm FY1617 Q3 JFM 10-Q Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark one)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2017
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                     
 
pglogoa01.jpg
THE PROCTER & GAMBLE COMPANY
(Exact name of registrant as specified in its charter)
 
 
Ohio
 
1-434
 
31-0411980
(State of Incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification Number)
One Procter & Gamble Plaza, Cincinnati, Ohio
 
45202
(Address of principal executive offices)
 
(Zip Code)
(513) 983-1100
(Registrant’s telephone number, including area code)
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ     No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes þ     No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act).
 
Large accelerated filer
 þ
 
 
Accelerated filer
 ¨
 
 
Non-accelerated filer
 ¨
(Do not check if smaller reporting company)
 
 
 
 
 
Smaller reporting company
 ¨
 
 
 
 
 
 
Emerging growth company
 ¨
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o     No þ
There were 2,557,614,388 shares of Common Stock outstanding as of March 31, 2017.



PART I. FINANCIAL INFORMATION 
Item 1.
Financial Statements


THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
 
Three Months Ended March 31
 
Nine Months Ended March 31
Amounts in millions except per share amounts
2017
 
2016
 
2017
 
2016
NET SALES
$
15,605

 
$
15,755

 
$
48,979

 
$
49,197

Cost of products sold
7,836

 
7,915

 
24,236

 
24,527

Selling, general and administrative expense
4,409

 
4,522

 
13,737

 
13,731

OPERATING INCOME
3,360

 
3,318

 
11,006

 
10,939

Interest expense
96

 
146

 
349

 
429

Interest income
46

 
33

 
123

 
135

Other non-operating income/(loss), net
26

 
21

 
(450
)
 
38

EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
3,336

 
3,226

 
10,330

 
10,683

Income taxes on continuing operations
780

 
889

 
2,338

 
2,664

NET EARNINGS FROM CONTINUING OPERATIONS
2,556

 
2,337

 
7,992

 
8,019

NET EARNINGS FROM DISCONTINUED OPERATIONS

 
446

 
5,217

 
627

NET EARNINGS
2,556

 
2,783

 
13,209

 
8,646

Less: Net earnings attributable to noncontrolling interests
34

 
33

 
98

 
89

NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
$
2,522

 
$
2,750

 
$
13,111

 
$
8,557

 
 
 
 
 
 
 
 
BASIC NET EARNINGS PER COMMON SHARE: (1)
 
 
 
 
 
 
 
Earnings from continuing operations
$
0.96

 
$
0.83

 
$
2.95

 
$
2.86

Earnings from discontinued operations

 
0.17

 
2.00

 
0.23

BASIC NET EARNINGS PER COMMON SHARE
0.96

 
1.00

 
4.95

 
3.09

DILUTED NET EARNINGS PER COMMON SHARE: (1)
 
 
 
 
 
 
 
Earnings from continuing operations
$
0.93

 
$
0.81

 
$
2.87

 
$
2.78

Earnings from discontinued operations

 
0.16

 
1.89

 
0.22

DILUTED NET EARNINGS PER COMMON SHARE
0.93

 
0.97

 
4.76

 
3.00

DIVIDENDS PER COMMON SHARE
$
0.6695

 
$
0.6630

 
$
2.0085

 
$
1.9890

Diluted weighted average common shares outstanding
2,705.5

 
2,835.0

 
2,755.4

 
2,855.6

(1) 
Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.


See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)
 
Three Months Ended March 31
 
Nine Months Ended March 31
Amounts in millions
2017
 
2016
 
2017
 
2016
NET EARNINGS
$
2,556

 
$
2,783

 
$
13,209

 
$
8,646

OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
 
 
 
 
 
 
 
Financial statement translation
726

 
1,041

 
(1,263
)
 
(937
)
Unrealized gains/(losses) on hedges
(192
)
 
(382
)
 
557

 
(172
)
Unrealized gains/(losses) on investment securities
4

 
36

 
(64
)
 
16

Unrealized gains/(losses) on defined benefit retirement plans
29

 
(3
)
 
722

 
231

TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
567

 
692

 
(48
)
 
(862
)
TOTAL COMPREHENSIVE INCOME/(LOSS)
3,123

 
3,475

 
13,161

 
7,784

Less: Total comprehensive income attributable to noncontrolling interests
34

 
33

 
98

 
89

TOTAL COMPREHENSIVE INCOME/(LOSS) ATTRIBUTABLE TO PROCTER & GAMBLE
$
3,089

 
$
3,442

 
$
13,063

 
$
7,695



See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
Amounts in millions
 
 
 
 
March 31, 2017
 
June 30, 2016
Assets
 
 
 
 
 
 
 
CURRENT ASSETS
 
 
 
 
 
 
 
Cash and cash equivalents
 
 
 
 
$
5,817

 
$
7,102

Available-for-sale investment securities
 
 
 
 
8,510

 
6,246

Accounts receivable
 
 
 
 
4,358

 
4,373

INVENTORIES
 
 
 
 
 
 
 
Materials and supplies
 
 
 
 
1,324

 
1,188

Work in process
 
 
 
 
505

 
563

Finished goods
 
 
 
 
2,925

 
2,965

Total inventories
 
 
 
 
4,754

 
4,716

Deferred income taxes
 
 
 
 

 
1,507

Prepaid expenses and other current assets
 
 
 
 
2,446

 
2,653

Current assets held for sale
 
 
 
 

 
7,185

TOTAL CURRENT ASSETS
 
 
 
 
25,885

 
33,782

PROPERTY, PLANT AND EQUIPMENT, NET
 
 
 
 
19,219

 
19,385

GOODWILL
 
 
 
 
43,682

 
44,350

TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET
 
 
 
24,153

 
24,527

OTHER NONCURRENT ASSETS
 
 
 
 
5,152

 
5,092

TOTAL ASSETS
 
 
 
 
$
118,091

 
$
127,136

 
 
 
 
 
 
 
 
Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
CURRENT LIABILITIES
 
 
 
 
 
 
 
Accounts payable
 
 
 
 
$
8,076

 
$
9,325

Accrued and other liabilities
 
 
 
 
7,225

 
7,449

Current liabilities held for sale
 
 
 
 

 
2,343

Debt due within one year
 
 
 
 
13,781

 
11,653

TOTAL CURRENT LIABILITIES
 
 
 
 
29,082

 
30,770

LONG-TERM DEBT
 
 
 
 
16,633

 
18,945

DEFERRED INCOME TAXES
 
 
 
 
8,644

 
9,113

OTHER NONCURRENT LIABILITIES
 
 
 
 
9,184

 
10,325

TOTAL LIABILITIES
 
 
 
 
63,543

 
69,153

SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
Preferred stock
 
 
 
 
1,010

 
1,038

Common stock – shares issued –
March 2017
 
4,009.2

 
 
 
 
 
June 2016
 
4,009.2

 
4,009

 
4,009

Additional paid-in capital
 
 
 
 
63,513

 
63,714

Reserve for ESOP debt retirement
 
 
 
 
(1,248
)
 
(1,290
)
Accumulated other comprehensive income/(loss)
 
 
 
 
(15,955
)
 
(15,907
)
Treasury stock
 
 
 
 
(93,225
)
 
(82,176
)
Retained earnings
 
 
 
 
95,736

 
87,953

Noncontrolling interest
 
 
 
 
708

 
642

TOTAL SHAREHOLDERS’ EQUITY
 
 
 
 
54,548

 
57,983

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
$
118,091

 
$
127,136


See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Nine Months Ended March 31
Amounts in millions
2017
 
2016
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
$
7,102

 
$
6,836

OPERATING ACTIVITIES
 
 
 
Net earnings
13,209

 
8,646

Depreciation and amortization
2,100

 
2,239

Loss on early extinguishment of debt
543

 

Share-based compensation expense
197

 
216

Deferred income taxes
(382
)
 
(428
)
Loss/(gain) on sale of assets
(5,452
)
 
241

Goodwill and intangible asset impairment charges

 
450

Changes in:
 
 
 
Accounts receivable
(159
)
 
(129
)
Inventories
(145
)
 
(94
)
Accounts payable, accrued and other liabilities
(1,113
)
 
(199
)
Other operating assets and liabilities
219

 
167

Other
48

 
187

TOTAL OPERATING ACTIVITIES
9,065

 
11,296

INVESTING ACTIVITIES
 
 
 
Capital expenditures
(2,230
)
 
(2,023
)
Proceeds from asset sales
411

 
114

Acquisitions, net of cash acquired
(16
)
 
(186
)
Purchases of short-term investments
(3,369
)
 
(2,372
)
Proceeds from sales and maturities of short-term investments
834

 
1,222

Pre-divestiture addition of restricted cash related to the Beauty Brands divestiture
(874
)
 
(995
)
Cash transferred at closing related to the Beauty Brands divestiture
(475
)
 

Release of restricted cash upon closing of the Beauty Brands divestiture
1,870

 

Cash transferred in Batteries divestiture

 
(143
)
Change in other investments
26

 

TOTAL INVESTING ACTIVITIES
(3,823
)
 
(4,383
)
FINANCING ACTIVITIES
 
 
 
Dividends to shareholders
(5,410
)
 
(5,589
)
Change in short-term debt
3,556

 
1,535

Additions to long-term debt
2,641

 
3,916

Reductions of long-term debt
(5,020
)
(1) 
(2,210
)
Treasury stock purchases
(4,504
)
 
(3,504
)
Shares exchanged in Batteries divestiture

 
(1,730
)
Impact of stock options and other
2,398

 
2,024

TOTAL FINANCING ACTIVITIES
(6,339
)
 
(5,558
)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
(188
)
 
(296
)
CHANGE IN CASH AND CASH EQUIVALENTS
(1,285
)
 
1,059

CASH AND CASH EQUIVALENTS, END OF PERIOD
$
5,817

 
$
7,895

(1) 
Includes $543 of costs related to early extinguishment of debt.

See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Basis of Presentation
These statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016. In the opinion of management, the accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries (the "Company," "Procter & Gamble," "P&G," "we" or "our") contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.

2. New Accounting Pronouncements and Policies
In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)". This guidance outlines a single, comprehensive model for accounting for revenue from contracts with customers. We plan to adopt the standard on July 1, 2018. While we are currently assessing the impact of the new standard, our revenue is primarily generated from the sale of finished product to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. These are largely un-impacted by the new standard. Therefore we do not expect this new guidance to have a material impact on our Consolidated Financial Statements.
In November 2015, the FASB issued ASU 2015-17, "Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes". This guidance simplifies the presentation of deferred taxes on the balance sheet by requiring that all deferred tax assets and liabilities be classified as non-current. The new standard is effective for us beginning July 1, 2017, with early adoption permitted. We elected to early adopt the new guidance on a prospective basis in the first quarter of fiscal year 2017. The impact was not significant.
In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)". The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. We plan to adopt the standard on July 1, 2019. We are currently assessing the impact that the new standard will have on our Consolidated Financial Statements, which will consist primarily of a balance sheet gross up of our operating leases to show equal and offsetting lease assets and lease liabilities.
In March 2016, the FASB issued ASU 2016-09, "Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" which changes the accounting for certain aspects of share-based payments to employees. The new guidance requires excess tax benefits (which represent the excess of actual tax benefits received at vest or settlement over the benefits recognized at issuance of share-based payments) and tax deficiencies (which represent the amount by which actual tax benefits received at vest or settlement is lower than the benefits recognized at issuance of share-based payments) to be recorded in the income statement when the awards vest or are settled. The amended guidance also requires excess tax benefits to be classified as an operating activity in the statement of cash flows, rather than a financing activity. The standard further provides an accounting policy election to account for forfeitures as they occur rather than utilizing the estimated amount of forfeitures at the time of issuance. The new standard is effective for us beginning July 1, 2017, with early adoption permitted. We elected to early adopt the new guidance on a prospective basis in the first quarter of fiscal year 2017. The primary impact of adoption was the recognition of excess tax benefits in our Income taxes on continuing operations rather than in Additional paid-in capital for fiscal year 2017. As a result, we recognized excess tax benefits of $189 in Income taxes on continuing operations during the nine months ended March 31, 2017. We also elected to adopt the cash flow presentation of the excess tax benefits prospectively commencing in the first quarter of fiscal 2017. We have elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost to be recognized in each period. None of the other provisions in this amended guidance had a significant impact on our Consolidated Financial Statements.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.


Amounts in millions of dollars unless otherwise specified.


3. Segment Information
As discussed in Note 11, the Beauty Brands and Batteries businesses are presented as discontinued operations and are excluded from segment results for all periods presented. Effective July 1, 2016, the Company began accounting for sales to and related earnings from its Venezuela subsidiaries in Corporate for management reporting purposes. As a result, we are also reflecting such sales and earnings in Corporate for segment reporting purposes. This change was made on a prospective basis for both management and external segment reporting purposes and did not have a significant impact on any of the segments.
Following is a summary of reportable segment results:
 
 
 
Three Months Ended March 31
 
Nine Months Ended March 31
 
 
 
Net Sales
 
Earnings/(Loss) from Continuing Operations Before Income Taxes
 
Net Earnings/(Loss) from Continuing Operations
 
Net Sales
 
Earnings/(Loss) from Continuing Operations Before Income Taxes
 
Net Earnings/(Loss) from Continuing Operations
Beauty
2017
 
$
2,675

 
$
531

 
$
396

 
$
8,613

 
$
2,028

 
$
1,528

 
2016
 
2,719

 
604

 
458

 
8,723

 
2,200

 
1,667

Grooming
2017
 
1,525

 
437

 
333

 
4,972

 
1,580

 
1,217

 
2016
 
1,623

 
469

 
356

 
5,103

 
1,547

 
1,187

Health Care
2017
 
1,841

 
470

 
310

 
5,774

 
1,574

 
1,052

 
2016
 
1,773

 
414

 
278

 
5,547

 
1,426

 
990

Fabric & Home Care
2017
 
4,957

 
972

 
599

 
15,529

 
3,226

 
2,052

 
2016
 
5,028

 
1,014

 
652

 
15,626

 
3,311

 
2,172

Baby, Feminine & Family Care
2017
 
4,471

 
890

 
555

 
13,711

 
2,973

 
1,932

 
2016
 
4,506

 
976

 
631

 
13,874

 
3,124

 
2,063

Corporate
2017
 
136

 
36

 
363

 
380

 
(1,051
)
 
211

 
2016
 
106

 
(251
)
 
(38
)
 
324

 
(925
)
 
(60
)
Total Company
2017
 
$
15,605

 
$
3,336

 
$
2,556

 
$
48,979

 
$
10,330

 
$
7,992

 
2016
 
15,755

 
3,226

 
2,337

 
49,197

 
10,683

 
8,019



Amounts in millions of dollars unless otherwise specified.


4. Goodwill and Other Intangible Assets
Goodwill is allocated by reportable segment as follows:
 
Beauty
 
Grooming
 
Health Care
 
Fabric & Home Care
 
Baby, Feminine & Family Care
 
Total Company
Goodwill at June 30, 2016
$
12,645

 
$
19,477

 
$
5,840

 
$
1,856

 
$
4,532

 
$
44,350

Acquisitions and divestitures

 

 
(10
)
 
(3
)
 

 
(13
)
Translation and other
(227
)
 
(259
)
 
(74
)
 
(24
)
 
(71
)
 
(655
)
Goodwill at March 31, 2017
$
12,418

 
$
19,218

 
$
5,756

 
$
1,829

 
$
4,461

 
$
43,682

On October 1, 2016, the Company completed the divestiture of four product categories, comprised of 41 of its beauty brands ("Beauty Brands"), to Coty, Inc. The transaction included the global salon professional hair care and color, retail hair color and cosmetics businesses and a majority of the fine fragrances business, along with select hair styling brands (see Note 11). The Beauty Brands have historically been part of the Company's Beauty reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the Beauty Brands are presented as discontinued operations. As a result, the goodwill attributable to the Beauty Brands as of June 30, 2016 is excluded from the preceding table and is reported as Current assets held for sale in the Consolidated Balance Sheets.
Goodwill decreased from June 30, 2016 primarily due to currency translation.
The test to evaluate goodwill for impairment is a two-step process. In the first step, we compare the fair value of the reporting unit to its carrying value. If the fair value of the reporting unit is less than its carrying value, we perform a second step to determine the implied fair value of the reporting unit's goodwill. The second step of the impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment.
The business unit valuations used to test goodwill and intangible assets for impairment are dependent on a number of significant estimates and assumptions including macroeconomic conditions, overall category growth rates, competitive activities, cost containment, margin expansion and Company business plans. We believe these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values.
Most of our goodwill reporting units are comprised of a combination of legacy and acquired businesses and as a result have fair value cushions that, at a minimum, exceed two times their underlying carrying values. Certain of our continuing goodwill reporting units, in particular Shave Care and Appliances, are comprised entirely of acquired businesses and as a result have fair value cushions that are not as high. While both of these wholly-acquired reporting units have fair value cushions that currently exceed the underlying carrying values, the Shave Care cushion, as well as the related indefinite-lived intangible asset cushion, have been reduced to below 10% due in large part to an increased competitive market environment in the U.S. and significant currency devaluations in a number of countries relative to the U.S. dollar that began in recent years. As a result, this unit is more susceptible to impairment risk from adverse changes in business operating plans and macroeconomic environment conditions, including any further significant devaluation of major currencies relative to the U.S. dollar. Any such adverse changes in the future could reduce the underlying cash flows used to estimate fair values and could result in a decline in fair value that could trigger future impairment charges of the business unit's goodwill and indefinite-lived intangibles (carrying values of Shave Care goodwill and the Gillette indefinite-lived intangible asset as of March 31, 2017 are $18.9 billion and $15.7 billion, respectively).
Identifiable intangible assets at March 31, 2017 are comprised of:
 
Gross Carrying Amount
 
Accumulated Amortization
Intangible assets with determinable lives
$
7,310

 
$
(4,757
)
Intangible assets with indefinite lives
21,600

 

Total identifiable intangible assets
$
28,910

 
$
(4,757
)
Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist of brands. The amortization expense of intangible assets for the three months ended March 31, 2017 and 2016 was $79 and $98, respectively. For the nine months ended March 31, 2017 and 2016, the amortization expense of intangible assets was $248 and $301, respectively.


Amounts in millions of dollars unless otherwise specified.


5. Earnings Per Share
Net earnings attributable to Procter & Gamble less preferred dividends (net of related tax benefits) are divided by the weighted average number of common shares outstanding during the period to calculate Basic net earnings per common share. Diluted net earnings per common share are calculated to give effect to stock options and other stock-based awards and assume conversion of preferred stock. Net earnings attributable to Procter & Gamble and common shares used to calculate Basic and Diluted net earnings per share were as follows:
 
Three Months Ended March 31, 2017
 
Three Months Ended March 31, 2016
CONSOLIDATED AMOUNTS
Continuing Operations
Discontinued Operations
Total
 
Continuing Operations
Discontinued Operations
Total
Net earnings
$
2,556

$

$
2,556

 
$
2,337

$
446

$
2,783

Net earnings attributable to noncontrolling interests
(34
)

(34
)
 
(32
)
(1
)
(33
)
Net earnings attributable to P&G (Diluted)
2,522


2,522

 
2,305

445

2,750

Preferred dividends, net of tax benefit
(60
)

(60
)
 
(63
)

(63
)
Net earnings attributable to P&G available to common shareholders (Basic)
$
2,462

$

$
2,462

 
$
2,242

$
445

$
2,687

 
 
 
 
 
 
 
 
SHARES IN MILLIONS
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
2,563.3

2,563.3

2,563.3

 
2,688.7

2,688.7

2,688.7

Effect of dilutive securities
 
 
 
 
 
 
 
Conversion of preferred shares (1)
98.7

98.7

98.7

 
103.4

103.4

103.4

Exercise of stock options and other unvested equity awards (2)
43.5

43.5

43.5

 
42.9

42.9

42.9

Diluted weighted average common shares outstanding
2,705.5

2,705.5

2,705.5

 
2,835.0

2,835.0

2,835.0

 
 
 
 
 
 
 
 
PER SHARE AMOUNTS (3)
 
 
 
 
 
 
 
Basic net earnings per common share
$
0.96

$

$
0.96

 
$
0.83

$
0.17

$
1.00

Diluted net earnings per common share
$
0.93

$

$
0.93

 
$
0.81

$
0.16

$
0.97

 
 
 
 
 
 
 
 
 
Nine Months Ended March 31, 2017
 
Nine Months Ended March 31, 2016
CONSOLIDATED AMOUNTS
Continuing Operations
Discontinued Operations
Total
 
Continuing Operations
Discontinued Operations
Total
Net earnings
$
7,992

$
5,217

$
13,209

 
$
8,019

$
627

$
8,646

Net earnings attributable to noncontrolling interests
(98
)

(98
)
 
(88
)
(1
)
(89
)
Net earnings attributable to P&G (Diluted)
7,894

5,217

13,111

 
7,931

626

8,557

Preferred dividends, net of tax benefit
(184
)

(184
)
 
(192
)

(192
)
Net earnings attributable to P&G available to common shareholders (Basic)
$
7,710

$
5,217

$
12,927

 
$
7,739

$
626

$
8,365

 
 
 
 
 
 
 
 
SHARES IN MILLIONS
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
2,611.5

2,611.5

2,611.5

 
2,709.2

2,709.2

2,709.2

Effect of dilutive securities
 
 
 
 
 
 
 
Conversion of preferred shares (1)
99.9

99.9

99.9

 
104.6

104.6

104.6

Exercise of stock options and other unvested equity awards (2)
44.0

44.0

44.0

 
41.8

41.8

41.8

Diluted weighted average common shares outstanding
2,755.4

2,755.4

2,755.4

 
2,855.6

2,855.6

2,855.6

 
 
 
 
 
 
 
 
PER SHARE AMOUNTS (3)
 
 
 
 
 
 
 
Basic net earnings per common share
$
2.95

$
2.00

$
4.95

 
$
2.86

$
0.23

$
3.09

Diluted net earnings per common share
$
2.87

$
1.89

$
4.76

 
$
2.78

$
0.22

$
3.00



Amounts in millions of dollars unless otherwise specified.


(1) 
Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.
(2) 
Weighted average outstanding stock options of approximately 7 million and 33 million for the three months ended March 31, 2017 and 2016, respectively, and approximately 16 million and 51 million for the nine months ended March 31, 2017 and 2016, respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
(3) 
Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

6. Share-Based Compensation and Postretirement Benefits
The following table provides a summary of our share-based compensation expense and postretirement benefit costs:
 
Three Months Ended March 31
 
Nine Months Ended March 31
 
2017
 
2016
 
2017
 
2016
Share-based compensation expense
$
93

 
$
79

 
$
211

 
$
220

Net periodic benefit cost for pension benefits (1)
77

 
85

 
430

 
256

Net periodic benefit cost/(credit) for other retiree benefits (1)
(23
)
 
(26
)
 
16

 
(75
)
(1) 
The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2016.
The disclosures above for both share-based compensation and postretirement benefits include amounts related to discontinued operations which were not material in any period presented.

7. Risk Management Activities and Fair Value Measurements
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the nine months ended March 31, 2017.
The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were remeasured at fair value on a non-recurring basis for the nine months ended March 31, 2017.
The following table sets forth the Company’s financial assets as of March 31, 2017 and June 30, 2016 that are measured at fair value on a recurring basis during the period:
 
Fair Value Asset
 
March 31, 2017
 
June 30, 2016
Investments
 
 
 
U.S. government securities
$
5,795

 
$
4,839

Corporate bond securities
2,715

 
1,407

Other investments
97

 
28

Total
$
8,607

 
$
6,274

Investment securities are presented in Available-for-sale investment securities and Other noncurrent assets. The amortized cost of U.S. government securities with maturities less than one year was $2,293 as of March 31, 2017 and $292 as of June 30, 2016. The amortized cost of U.S. government securities with maturities between one and five years was $3,525 as of March 31, 2017 and $4,513 as of June 30, 2016. The amortized cost of Corporate bond securities with maturities of less than a year was $574 as of March 31, 2017 and $382 as of June 30, 2016. The amortized cost of Corporate bond securities with maturities between one and five years was $2,148 as of March 31, 2017 and $1,018 as of June 30, 2016. The Company's investments measured at fair value are generally classified as Level 2 within the fair value hierarchy. There are no material investment balances classified as

Amounts in millions of dollars unless otherwise specified.


either Level 1 or Level 3 within the fair value hierarchy. Fair values are generally estimated based upon quoted market prices for similar instruments.
The fair value of long-term debt was $19,905 and $24,362 as of March 31, 2017 and June 30, 2016, respectively. This includes the current portion ($1,670 and $2,761 as of March 31, 2017 and June 30, 2016, respectively) of debt instruments. Certain long-term debt is recorded at fair value. Certain long-term debt is not recorded at fair value on a recurring basis but is measured at fair value for disclosure purposes. Long-term debt with fair value of $1,705 and $2,331 as of March 31, 2017 and June 30, 2016, respectively, is classified as Level 2 within the fair value hierarchy. All remaining long-term debt is classified as Level 1 within the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.
The following table sets forth the notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of March 31, 2017 and June 30, 2016:
 
Notional Amount
 
Fair Value Asset/(Liability)
 
March 31, 2017
 
June 30, 2016
 
March 31, 2017
 
June 30, 2016
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
Foreign currency contracts
$
798

 
$
798

 
$
90

 
$
31

Derivatives in Fair Value Hedging Relationships
 
 
 
 
 
 
 
Interest rate contracts
$
4,418

 
$
4,993

 
$
169

 
$
371

Derivatives in Net Investment Hedging Relationships
 
 
 
 
 
 
 
Net investment hedges
$
2,902

 
$
3,013

 
$
90

 
$
(87
)
Derivatives Not Designated as Hedging Instruments
 
 
 
 
 
 
 
Foreign currency contracts
$
4,845

 
$
6,482

 
$
51

 
$
(10
)
All derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. All derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. The total notional amount of contracts outstanding at the end of the period is indicative of the Company's derivative activity during the period. The change in the notional balance of foreign currency contracts not designated as hedging instruments during the period reflects changes in the level of intercompany financing activity. All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.
 
Amount of Gain/(Loss) Recognized in AOCI on Derivatives (Effective Portion)
 
March 31, 2017
 
June 30, 2016
Derivatives in Cash Flow Hedging Relationships
 
 
 
Interest rate contracts
$
(2
)
 
$
(2
)
Foreign currency contracts
(4
)
 

Total
$
(6
)
 
$
(2
)
Derivatives in Net Investment Hedging Relationships
 
 
 
Net investment hedges
$
54

 
$
(53
)
During the next 12 months, the amount of the March 31, 2017 Accumulated other comprehensive income (AOCI) balance that will be reclassified to earnings is expected to be immaterial.

Amounts in millions of dollars unless otherwise specified.


The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three and nine months ended March 31, 2017 and 2016 are as follows:
 
Amount of Gain/(Loss) Reclassified from AOCI into Earnings
 
Three Months Ended March 31
 
Nine Months Ended March 31
 
2017
 
2016
 
2017
 
2016
Derivatives in Cash Flow Hedging Relationships (1)
 
 
 
 
 
 
 
Interest rate contracts
$

 
$

 
$

 
$
3

Foreign currency contracts
(25
)
 
(43
)
 
74

 
(44
)
Total
$
(25
)
 
$
(43
)
 
$
74

 
$
(41
)
 
 
 
 
 
 
 
 
 
Amount of Gain/(Loss) Recognized in Earnings
 
Three Months Ended March 31
 
Nine Months Ended March 31
 
2017
 
2016
 
2017
 
2016
Derivatives in Fair Value Hedging Relationships (2)
 
 
 
 
 
 
 
Interest rate contracts
$
(22
)
 
$
132

 
$
(202
)
 
$
171

Debt
22

 
(132
)
 
202

 
(171
)
Total
$

 
$

 
$

 
$

Derivatives in Net Investment Hedging Relationships (2)
 
 
 
 
 
 
 
Net investment hedges
$
6

 
$

 
$
6

 
$

Derivatives Not Designated as Hedging Instruments (3)
 
 
 
 
 
 
 
Foreign currency contracts
$
155

 
$
191

 
$
(29
)
 
$
(29
)
(1) 
The gain or loss on the effective portion of cash flow hedging relationships is reclassified from AOCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in Interest expense and foreign currency contracts in Selling, general and administrative expense (SG&A) and Interest expense.
(2) 
The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in Interest expense.
(3) 
The gain or loss on foreign currency contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings in SG&A. This gain or loss substantially offsets the foreign currency mark-to-market impact of the related exposure.


Amounts in millions of dollars unless otherwise specified.


8. Accumulated Other Comprehensive Income/(Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) by component and the reclassifications out of Accumulated other comprehensive income/(loss):
 
Changes in Accumulated Other Comprehensive Income/(Loss) by Component
 
Hedges
 
Investment Securities
 
Pension and Other Retiree Benefits
 
Financial Statement Translation
 
Total
Balance at June 30, 2016
$
(2,641
)
 
$
34

 
$
(5,798
)
 
$
(7,502
)
 
$
(15,907
)
OCI before reclassifications (1)
631

 
(56
)
 
338

 
(1,146
)
 
(233
)
Amounts reclassified from AOCI (2) (3) (4)
(74
)
 
(8
)
 
384

 
(117
)
 
185

Net current period OCI
557

 
(64
)
 
722

 
(1,263
)
 
(48
)
Balance at March 31, 2017
$
(2,084
)
 
$
(30
)
 
$
(5,076
)
 
$
(8,765
)
 
$
(15,955
)
(1) 
Net of tax expense/(benefit) of $337, $(6) and $91 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
(2) 
Net of tax expense/(benefit) of $0, $0 and $151 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
(3) 
See Note 7 for classification of gains and losses from hedges in the Consolidated Statements of Earnings. Gains and losses on investment securities are reclassified from AOCI into Other non-operating income/(loss), net. Gains and losses on pension and other retiree benefits are reclassified from AOCI into Cost of products sold and SG&A and are included in the computation of net periodic pension costs.
(4) 
Amounts reclassified from AOCI for financial statement translation relate to accumulated translation associated with foreign entities sold as part of the sale of the Beauty Brands business. These amounts were reclassified into Net earnings from discontinued operations in the Consolidated Statement of Earnings.

9. Restructuring Program
The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before-tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. In fiscal 2012, the Company initiated an incremental restructuring program as part of a productivity and cost savings plan to reduce costs in the areas of supply chain, research and development, marketing and overheads. The productivity and cost savings plan was designed to accelerate cost reductions by streamlining management decision making, manufacturing and other work processes in order to help fund the Company's growth strategy.
The Company expects to incur approximately $5.5 billion in before-tax restructuring costs over a six year period (from fiscal 2012 through fiscal 2017), including costs incurred as part of the ongoing and incremental restructuring program. The program includes a non-manufacturing overhead enrollment reduction target of approximately 25% - 30% by the end of fiscal 2017.
Through March 31, 2017, the Company reduced non-manufacturing enrollment by approximately 26%. The reductions are enabled by the elimination of duplicate work, simplification through the use of technology and optimization of various functional and business organizations and the Company's global footprint. In addition, the plan includes integration of newly acquired companies and the optimization of the supply chain and other manufacturing processes.
Restructuring costs incurred consist primarily of costs to separate employees, asset-related costs to exit facilities and other costs. Through fiscal 2016, the Company incurred charges of approximately $4.9 billion. Approximately $2.3 billion of these charges were related to separations, $1.4 billion were asset-related costs and $1.2 billion were related to other restructuring-type costs.
For the three and nine month periods ended March 31, 2017, the Company incurred total restructuring charges of approximately $157 and $505, respectively. For the three and nine month periods ended March 31, 2017, $25 and $72 of these charges were recorded in SG&A, respectively. For the three and nine month periods ended March 31, 2017, $132 and $409 of these charges were recorded in Cost of products sold, respectively. The remainder of the charges were included in discontinued operations. The following table presents restructuring activity for the nine months ended March 31, 2017:
 
 
 
 
 
 
 
Nine Months Ended March 31, 2017
 
 
 
Accrual Balance June 30, 2016
 
Charges Previously Reported (Six Months Ended December 31, 2016)
 
Charges for the Three Months Ended March 31, 2017
 
Cash Spent (1)
 
Charges Against Assets
 
Accrual Balance March 31, 2017
Separations
$
243

 
$
96

 
$
43

 
$
(182
)
 
$

 
$
200

Asset-related costs

 
206

 
80

 

 
(286
)
 

Other costs
72

 
46

 
34

 
(104
)
 

 
48

Total
$
315

 
$
348

 
$
157

 
$
(286
)
 
$
(286
)
 
$
248

(1) 
Includes liabilities transferred to Coty related to our Beauty Brands divestiture.
Separation Costs
Employee separation charges for the three and nine month periods ended March 31, 2017 relate to severance packages for approximately 480 and 1,520 employees, respectively. Separations related to non-manufacturing employees were approximately 70 and 260 employees for the three and nine month periods ended March 31, 2017, respectively. The packages are predominantly voluntary and the amounts are calculated based on salary levels and past service periods. Severance costs related to voluntary separations are generally charged to earnings when the employee accepts the offer. Since its inception, the restructuring program has incurred separation charges related to approximately 18,590 employees, of which approximately 9,800 are non-manufacturing overhead personnel.
Asset-Related Costs
Asset-related costs consist of both asset write-downs and accelerated depreciation. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or disposal. These assets were written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. These assets relate primarily to manufacturing consolidations and technology standardizations. The asset-related charges will not have a significant impact on future depreciation charges.
Other Costs
Other restructuring-type charges are incurred as a direct result of the restructuring program. Such charges primarily include employee relocation related to separations and office consolidations, termination of contracts related to supply chain redesign and the cost to change internal systems and processes to support the underlying organizational changes.
Consistent with our historical policies for ongoing restructuring-type activities, the restructuring program charges are funded by and included within Corporate for both management and segment reporting. Accordingly, all of the charges under the program are included within the Corporate reportable segment. However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments:
 
Three Months Ended March 31, 2017
 
Nine Months Ended March 31, 2017
Beauty
$
23

 
$
63

Grooming
14

 
31

Health Care
1

 
9

Fabric & Home Care
26

 
103

Baby, Feminine & Family Care
41

 
141

Corporate (1)
52

 
158

Total Company
$
157

 
$
505

(1) 
Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities, and costs related to discontinued operations from our Beauty Brands businesses.


Amounts in millions of dollars unless otherwise specified.


10. Commitments and Contingencies
Litigation
The Company is subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark, advertising, contracts, environmental, labor and employment and tax. With respect to these and other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.
We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.
Income Tax Uncertainties
The Company is present in approximately 140 taxable jurisdictions and, at any point in time, has 5060 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2008 and forward. We are generally not able to reliably estimate the ultimate settlement amounts until the close of the audit. Based on information currently available, we anticipate that over the next 12 month period, audit activity could be completed related to uncertain tax positions in multiple jurisdictions for which we have accrued liabilities of approximately $170, including interest and penalties.
Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the year ended June 30, 2016.

11. Discontinued Operations
On October 1, 2016, the Company completed the divestiture of four product categories to Coty, Inc. (“Coty”). The divestiture included 41 of the Company's beauty brands (“Beauty Brands”), including the global salon professional hair care and color, retail hair color, cosmetics and a majority of the fine fragrance businesses, along with select hair styling brands. The form of the divestiture transaction was a Reverse Morris Trust split-off, in which P&G shareholders were given the election to exchange their P&G shares for shares of a new corporation that held the Beauty Brands (Galleria Co.), and then immediately exchange those shares for Coty shares. The value P&G received in the transaction was $11.4 billion. The value is comprised of 105 million shares of common stock of the Company, which were tendered by shareholders of the Company and exchanged for the Galleria Co. shares, valued at approximately $9.4 billion, and the assumption of $1.9 billion of debt by Galleria Co.. The shares tendered in the transaction were reflected as an addition to treasury stock and the cash received related to the debt assumed by Coty was reflected as an investing activity in the Consolidated Statement of Cash Flows. The Company recorded an after-tax gain on the final transaction of $5.3 billion, net of transaction and related costs.
Two of the fine fragrance brands, Dolce & Gabbana and Christina Aguilera, were excluded from the divestiture. These brands were subsequently divested at amounts that approximated their adjusted carrying values.
In February 2016, the Company completed the divestiture of its Batteries business to Berkshire Hathaway (BH) via a split transaction, in which the Company exchanged Duracell, which the Company had infused with approximately $1.9 billion of additional cash, to repurchase all 52.5 million shares of P&G stock owned by BH. During fiscal 2016, the Company recorded a non-cash, before-tax goodwill and indefinite-lived asset impairment charge of $402 ($350 after-tax), to reduce the value to the total estimated proceeds based on the value of BH’s shares in P&G stock at the time of the impairment charges. The Company recorded an after-tax gain on the final transaction of $422 to reflect the final value of the BH’s shares in P&G stock. The total value of the transaction was $4.2 billion representing the value of the Duracell business and the cash infusion. The cash infusion was reflected as a purchase of treasury stock.
In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the Beauty Brands and Batteries business are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Additionally, the Beauty Brands' balance sheet positions are presented as assets and liabilities held for sale in the Consolidated Balance Sheets as of June 30, 2016. The Beauty Brands were historically part of the Company's Beauty reportable segment. The Batteries business was historically part of the Company's Fabric & Home Care reportable segment.

Amounts in millions of dollars unless otherwise specified.


On July 1, 2015, the Company adopted ASU 2014-08, which included new reporting and disclosure requirements for discontinued operations. The new requirements are effective for discontinued operations occurring on or after the adoption date, which includes the Beauty Brands divestiture. All other discontinued operations prior to July 1, 2015 are reported based on the previous disclosure requirements for discontinued operations, including the Batteries divestiture.
The following table summarizes Net earnings/(loss) from discontinued operations and reconciles to the Consolidated Statements of Earnings:
 
Three Months Ended March 31
 
Nine Months Ended March 31
 
2017
 
2016
 
2017
 
2016
Beauty Brands
$

 
$
(2
)
 
$
5,217

 
$
386

Batteries

 
448

 

 
241

Net earnings/(loss) from discontinued operations
$

 
$
446

 
$
5,217

 
$
627

The following is selected financial information underlying the Net earnings/(loss) from discontinued operations for the Beauty Brands:
 
Beauty Brands
 
Three Months Ended March 31
 
Nine Months Ended March 31
 
2017
 
2016
 
2017
 
2016
Net sales
$

 
$
1,092

 
$
1,159

 
$
3,715

Cost of products sold

 
365

 
450

 
1,193

Selling, general and administrative expense

 
672

 
783

 
1,983

Interest expense

 

 
14

 

Intangible asset impairment charges

 
48

 

 
48

Other non-operating income/(loss), net

 
(6
)
 
16

 
(8
)
Earnings/(loss) from discontinued operations before income taxes
$

 
$
1

 
$
(72
)
 
$
483

Income taxes on discontinued operations

 
3

 
46

 
97

Gain on sale of business before income taxes
$

 
$

 
$
5,197

 
$

Income tax expense/(benefit) on sale of business

 

 
(138
)
(1) 

Net earnings/(loss) from discontinued operations
$

 
$
(2
)
 
$
5,217

 
$
386

(1) 
The income tax benefit of the Beauty Brands divestiture represents the reversal of underlying deferred tax balances partially offset by current tax expense related to the transaction.
The Beauty Brands incurred transition costs of $167, after-tax, for the three months ended September 30, 2016, included in the above table. Residual transaction costs for the three months ended December 31, 2016 are included in the gain on the sale of business in the table above.
The following is selected financial information related to cash flows from discontinued operations for the Beauty Brands:
 
Beauty Brands
 
Nine Months Ended March 31
 
2017
 
2016
NON-CASH OPERATING ITEMS
 
 
 
Depreciation and amortization
$
24

 
$
78

Deferred income tax benefit
(649
)
 

Before tax gain on sale of business
5,210

 

Goodwill and intangible asset impairment charges
$

 
$
48

Net increase in accrued taxes
307

 

CASH FLOWS FROM OPERATING ACTIVITIES
 
 
 
Cash taxes paid
$
204

 
$

CASH FLOWS FROM INVESTING ACTIVITIES
 
 
 
Capital expenditures
$
38

 
$
65


Amounts in millions of dollars unless otherwise specified.


The major components of assets and liabilities of the Beauty Brands held for sale are provided below.
 
Beauty Brands
 
June 30, 2016
Cash
$
40

Restricted cash
996

Accounts receivable
384

Inventories
494

Prepaid expenses and other current assets
126

Property, plant and equipment, net
629

Goodwill and intangible assets, net
4,411

Other noncurrent assets
105

Current assets held for sale
$
7,185

 
 
Accounts payable
$
148

Accrued and other liabilities
384

Noncurrent deferred tax liabilities
370

Long-term debt
996

Other noncurrent liabilities
445

Current liabilities held for sale
$
2,343

Prior to the transaction, Beauty Brands drew $1.9 billion of debt ($1.0 billion as of June 30, 2016), which as noted above, was used to fund a portion of the transaction. The proceeds were held by the Beauty Brands as of June 30, 2016. In connection with the closing, this cash reverted to the Company and was used to retire P&G debt as part of a broader $2.5 billion debt retirement program that was completed in November 2016.
The following is selected financial information included in Net earnings/(loss) from discontinued operations for the Batteries business:
 
Batteries
 
Three Months Ended March 31, 2016
 
Nine Months Ended March 31, 2016
Net sales
$
320

 
$
1,517

Earnings before impairment charges and income taxes
35

 
266

Impairment charges

 
(402
)
Income tax (expense)/benefit
(9
)
 
(45
)
Gain on sale before income taxes
(288
)
 
(288
)
Income tax expense on sale (1)
710

 
710

Net earnings/(loss) from discontinued operations
$
448

 
$
241

(1) 
The income tax benefit of the Batteries divestiture primarily represents the reversal of underlying deferred tax balances.

Amounts in millions of dollars unless otherwise specified.


Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: “Management's Discussion and Analysis,” “Risk Factors,” and Notes 4 and 10 to the Consolidated Financial Statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to factors outside of our control, such as natural disasters and acts of war or terrorism; (5) the ability to successfully manage cost fluctuations and pressures, including commodity prices, raw materials, labor costs, energy costs and pension and health care costs; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third party relationships, such as our suppliers, contractors and external business partners; (11) the ability to rely on and maintain key information technology systems and networks (including Company and third-party systems and networks) and maintain the security and functionality of such systems and networks and the data contained therein; (12) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, intellectual property, antitrust, privacy, tax, accounting standards and environmental) and to resolve pending matters within current estimates; (13) the ability to manage changes in applicable tax laws and regulations; (14) the ability to successfully manage our portfolio optimization strategy, including achieving and maintaining our intended tax treatment of the related transactions, and our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining particularly key employees, especially in key growth markets where the availability of skilled or experienced employees may be limited; and (16) the ability to manage the uncertain implications of the United Kingdom’s withdrawal from the European Union. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from those projected herein is included in the section titled "Economic Conditions and Uncertainties" and the section titled “Risk Factors” (Part II, Item 1A of this Form 10-Q).
The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying notes. The MD&A is organized in the following sections:
Overview
Summary of Results – Nine Months Ended March 31, 2017
Economic Conditions and Uncertainties
Results of Operations – Three and Nine Months Ended March 31, 2017
Business Segment Discussion – Three and Nine Months Ended March 31, 2017
Liquidity and Capital Resources
Reconciliation of Measures Not Defined by U.S. GAAP

Throughout the MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net sales and net earnings. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth, core net earnings per share (Core EPS), adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the definition of these non-GAAP measures as well as details on the use and the derivation of these measures.
Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and market consumption in the MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. All market share references represent the percentage of sales in dollar terms on a constant currency basis of our products, relative to all product sales in the category.
OVERVIEW
P&G is a global leader in fast-moving consumer goods, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in more than 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies. We have on-the-ground operations in approximately 70 countries.
Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-premium, premium, mid-tier and value-tier products). We are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.
The table below provides detail on our reportable segments, including the product categories and brand composition within each segment.
Reportable Segments
Product Categories (Sub-Categories)
Major Brands
Beauty
Hair Care (Conditioner, Shampoo, Styling Aids, Treatments)
Head & Shoulders, Pantene, Rejoice
Skin and Personal Care (Antiperspirant and Deodorant, Personal Cleansing, Skin Care)
Olay, Old Spice, Safeguard, SK-II
Grooming
Grooming (1) (Shave Care - Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care; Appliances)
Braun, Fusion, Gillette, Mach3, Prestobarba, Venus
Health Care
Oral Care (Toothbrushes, Toothpaste, Other Oral Care)
Crest, Oral-B
Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care)
Prilosec, Vicks
Fabric & Home Care
Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents)
Ariel, Downy, Gain, Tide
Home Care (Air Care, Dish Care, P&G Professional, Surface Care)
Cascade, Dawn, Febreze, Mr. Clean, Swiffer
Baby, Feminine & Family Care
Baby Care (Baby Wipes, Diapers and Pants)
Luvs, Pampers
Feminine Care (Adult Incontinence, Feminine Care)
Always, Tampax
Family Care (Paper Towels, Tissues, Toilet Paper)
Bounty, Charmin
(1) 
The Grooming product category is comprised of the Shave Care and Appliances Global Business Units.
The following table provides the percentage of net sales and net earnings by reportable business segment for the three and nine months ended March 31, 2017 (excluding net sales and net earnings in Corporate):
 
Three Months Ended March 31
 
Nine Months Ended March 31
 
Net Sales
 
Net Earnings
 
Net Sales
 
Net Earnings
Beauty
17%
 
18%
 
18%
 
20%
Grooming
10%
 
15%
 
10%
 
16%
Health Care
12%
 
14%
 
12%
 
13%
Fabric & Home Care
32%
 
28%
 
32%
 
26%
Baby, Feminine & Family Care
29%
 
25%
 
28%
 
25%
Total Company
100%
 
100%
 
100%
 
100%
SUMMARY OF RESULTS
Following are highlights of results for the nine months ended March 31, 2017 versus the nine months ended March 31, 2016:
Net sales were unchanged versus the previous period at $49.0 billion. Organic sales, which exclude the impacts of acquisitions and divestitures and foreign exchange, increased 2%. Organic sales increased 2% in Beauty, 7% in Health Care, 2% in Fabric & Home Care, 1% in Baby, Feminine & Family Care and were unchanged in Grooming.
Unit volume increased 1% with organic volume up 2%. Volume increased mid-single digits in Health Care and low single digits in Fabric & Home Care, Baby, Feminine & Family Care and Grooming. Volume decreased low single digits in Beauty. Excluding the impacts of minor brand divestitures, organic volume increased low single digits in Beauty.
Net earnings from continuing operations were $8.0 billion, unchanged versus the prior year period. An increase in operating income, primarily driven by gains on the sale of real estate, and the benefit of a lower effective tax rate were offset by an increase in other non-operating expense due mainly to a charge related to early extinguishment of certain long-term debt.
Diluted net earnings per share from continuing operations increased 3% to $2.87 due to reduced shares outstanding from shares tendered in the divestiture of the Beauty Brands to Coty.
Net earnings attributable to Procter & Gamble were $13.1 billion, an increase of $4.6 billion or 53% versus the prior year period, primarily driven by the $5.3 billion after-tax gain on the sale of the Beauty Brands in the current period partially offset by the base-period results of discontinued operations, including the net results of the Beauty Brands and a gain on the sale of the Batteries business.
Core net earnings attributable to Procter & Gamble, which excludes discontinued operations, the charge related to early extinguishment of certain long-term debt and incremental restructuring charges, increased 3% to $8.5 billion. Core net earnings per share increased 7% to $3.07 due to the increase in core net earnings and the reduction in shares outstanding.
Operating cash flow was $9.1 billion. Adjusted free cash flow, which is operating cash flow less capital expenditures and excluding tax payments related to the sale of the Beauty Brands, was $7.0 billion. Adjusted free cash flow productivity, which is the ratio of adjusted free cash flow to net earnings excluding a loss on early debt extinguishment and the gain on sale of the Beauty business, was 86%.
ECONOMIC CONDITIONS AND UNCERTAINTIES
Global Economic Conditions. Current macroeconomic factors remain dynamic, and any causes of market size contraction, such as reduced GDP in commodity-dependent economies, greater political unrest in the Middle East and Eastern Europe, further economic instability in the European Union, political instability in certain Latin American markets and economic slowdowns in Japan and China, could reduce our sales or erode our operating margin, in either case reducing our earnings.
Changes in Costs. Our costs are subject to fluctuations, particularly due to changes in commodity prices and our own productivity efforts. We have significant exposures to certain commodities, in particular certain oil-derived materials like resins, and volatility in the market price of these commodity input materials has a direct impact on our costs. If we are unable to manage commodity fluctuations through pricing actions, cost savings projects and sourcing decisions as well as through consistent productivity improvements, it may adversely impact our gross margin, operating margin and net earnings. Sales could also be adversely impacted following pricing actions if there is a negative impact on consumption of our products. We strive to implement, achieve and sustain cost improvement plans, including outsourcing projects, supply chain optimization and general overhead and workforce optimization. As discussed later in this MD&A, we initiated certain non-manufacturing overhead reduction projects along with manufacturing and other supply chain cost improvements projects in 2012. If we are not successful in executing and sustaining these changes, there could be a negative impact on our operating margin and net earnings.
Foreign Exchange. We have both translation and transaction exposure to the fluctuation of exchange rates. Translation exposures relate to exchange rate impacts of measuring income statements of foreign subsidiaries that do not use the U.S. dollar as their functional currency. Transaction exposures relate to 1) the impact from input costs that are denominated in a currency other than the local reporting currency and 2) the revaluation of transaction-related working capital balances denominated in currencies other than the functional currency. Over the past four years, the U.S. dollar has strengthened versus a number of foreign currencies leading to lower sales and earnings from these foreign exchange impacts. Certain countries experiencing significant exchange rate fluctuations, like Argentina, Egypt, Nigeria, and the United Kingdom have had, and could continue to have, a significant impact on our sales, costs and earnings. Increased pricing in response to these fluctuations in foreign currency exchange rates may offset portions of the currency impacts but could also have a negative impact on consumption of our products, which would affect our sales.
Government Policies. Our net earnings could be affected by changes in U.S. or foreign government tax policies. For example, the U.S. is considering corporate tax reform that may significantly impact the corporate tax rate and change the U.S. tax treatment of international earnings. Additionally, we attempt to carefully manage our debt and currency exposure in certain countries with currency exchange, import authorization and pricing controls, such as Nigeria and Ukraine. Changes in government policies in these areas might cause an increase or decrease in our sales, operating margin and net earnings. For example, during fiscal 2015, the Company deconsolidated its Venezuelan subsidiaries due to evolving conditions that resulted in an other-than-temporary lack of exchangeability between the Venezuelan bolivar and U.S. dollar and restricted our ability to pay dividends and satisfy certain other obligations denominated in U.S. dollars.
For information on risk factors that could impact our results, please refer to Part II, Item 1A "Risk Factors" in the Company’s Form 10-Q for the quarterly period ended December 31, 2016.
RESULTS OF OPERATIONS – Three Months Ended March 31, 2017
The following discussion provides a review of results for the three months ended March 31, 2017 versus the three months ended March 31, 2016.
 
Three Months Ended March 31
Amounts in millions, except per share amounts
2017
 
2016
 
% Chg
Net sales
$
15,605

 
$
15,755

 
(1
)%
Operating income
3,360

 
3,318

 
1
 %
Net earnings from continuing operations
2,556

 
2,337

 
9
 %
Net earnings from discontinued operations

 
446

 
(100
)%
Net earnings attributable to Procter & Gamble
2,522

 
2,750

 
(8
)%
Diluted net earnings per common share
0.93

 
0.97

 
(4
)%
Diluted net earnings per share from continuing operations
0.93

 
0.81

 
15
 %
Core net earnings per common share
0.96

 
0.86

 
12
 %
 
 
Three Months Ended March 31
COMPARISONS AS A % OF NET SALES
2017
 
2016
 
Basis Pt Chg
Gross profit
49.8%
 
49.8%
 
Selling, general & administrative expense
28.3%
 
28.7%
 
(40)
Operating income
21.5%
 
21.1%
 
40
Earnings from continuing operations before income taxes
21.4%
 
20.5%
 
90
Net earnings from continuing operations
16.4%
 
14.8%
 
160
Net earnings attributable to Procter & Gamble
16.2%
 
17.5%
 
(130)
Net Sales
Net sales for the quarter decreased 1% to $15.6 billion. Unit volume was unchanged. Unfavorable foreign exchange reduced net sales by 2%. Pricing and mix had no net impact on consolidated net sales. Volume increased mid-single digits in Health Care and low single digits in Baby, Feminine & Family Care. Volume was unchanged in Fabric & Home Care and Grooming and decreased low single digits in Beauty driven by minor brand divestitures. Volume increased low single digits in developed regions and was unchanged in developing regions. Organic sales increased 1% driven by a 1% increase in organic volume.
 
Net Sales Change Drivers 2017 vs. 2016 (Three Months Ended March 31)*
 
Volume with Acquisitions & Divestitures
 
Volume Excluding Acquisitions & Divestitures
 
Foreign Exchange
 
Price
 
Mix
 
Other**
 
Net Sales Growth
Beauty
(2)%
 
—%
 
(1)%
 
1%
 
—%
 
—%
 
(2)%
Grooming
—%
 
—%
 
—%
 
(2)%
 
(4)%
 
—%
 
(6)%
Health Care
4%
 
4%
 
(1)%
 
1%
 
1%
 
(1)%
 
4%
Fabric & Home Care
—%
 
1%
 
(2)%
 
—%
 
—%
 
1%
 
(1)%
Baby, Feminine & Family Care
1%
 
1%
 
(1)%
 
—%
 
—%
 
(1)%
 
(1)%
Total Company
—%
 
1%
 
(2)%
 
—%
 
—%
 
1%
 
(1)%
* Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
** Other includes the sales mix impact from acquisitions/divestitures and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin was unchanged at 49.8% of net sales for the quarter. Gross margin benefited from a 210 basis point impact from total manufacturing cost savings (180 basis points net of product and packaging reinvestments), a 40 basis point impact from lower incremental restructuring charges and a 10 basis point impact from increased volume scale leverage. These impacts were offset by a 100 basis point decline from unfavorable product mix (primarily between segments caused by the disproportionate net sales declines in Beauty and Grooming, both of which have higher than company-average gross margins, and within segments due to disproportionate growth of lower margin products), a 80 basis point decline due to higher commodity costs, a 20 basis point negative impact from unfavorable foreign exchange and 30 basis points from other impacts, including costs incurred from tornado damage to a U.S. Family Care distribution facility.
Total SG&A spending decreased 2% to $4.4 billion as a reduction in other operating expense, primarily from a gain on the sale of real estate, was partially offset by increases in marketing and overhead spending. SG&A as a percentage of net sales decreased 40 basis points to 28.3%, as a 130 basis point benefit in other operating income, including the gain on the sale of real estate, was partially offset by increases in overhead and marketing as a percent of net sales. Overhead costs as percent of net sales increased 70 basis points as wage inflation and investments in R&D and sales resources were partially offset by cost savings. Marketing spending as a percent of net sales increased 20 basis points as investments in advertising were partially offset by reductions in agency compensation. Overall cost savings delivered 50 basis points of benefit in SG&A.
Non-Operating Expenses and Income
Interest expense was $96 million for the quarter, a decrease of $50 million versus the prior year period, due to a decrease in weighted average interest rates and a decline in the average debt outstanding. Interest income was $46 million for the quarter, an increase of $13 million versus the prior year period due to an increase in interest-bearing cash and cash equivalents. Other non-operating income/(loss) was $26 million, an increase of $5 million.
Income Taxes on Continuing Operations
The effective tax rate on continuing operations decreased 420 basis points to 23.4%. The decline was due to impacts from excess tax benefits associated with share-based payments due to the adoption of FASB Accounting Standards Update (ASU) 2016-09 Improvements to Employee Share-based Payment Accounting (180 basis points), discrete impacts related to uncertain income tax positions (which netted to 140 basis points in the current year versus zero in the prior year), and the prior year establishment of a valuation allowance on deferred tax assets related to net operating loss carryforwards (270 basis points). These benefits were partially offset by unfavorable geographic mix, primarily due to a higher proportion of U.S. earnings.
Net Earnings from Continuing Operations
Net earnings from continuing operations increased $219 million or 9% to $2.6 billion for the quarter. This increase was driven by the lower effective tax rate and reduced interest expense along with a 1% increase in operating income. Foreign exchange impacts reduced net earnings by about $80 million for the quarter due to weakening of certain key currencies against the U.S. dollar, primarily the currencies of Egypt, Turkey and the United Kingdom. This impact includes both transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Diluted net earnings per share from continuing operations increased 15% to $0.93 due to the increase in net earnings and a reduction in number of weighted average shares outstanding following the shares tendered in the sale of the Beauty Brands to Coty (see Note 11 to the Consolidated Financial Statements), along with ongoing share repurchases.
Discontinued Operations
Net earnings from discontinued operations were zero in the current period versus $446 million in the prior year. The base period result was driven primarily by a gain on sale of the Batteries business. The sale of the Beauty Brands closed in the second fiscal quarter of the current year. Accordingly, there are no results of discontinued operations reported in the quarter ended March 31, 2017 (see Note 11 to the Consolidated Financial Statements).
Net Earnings
Net earnings attributable to Procter & Gamble decreased $228 million or 8% to $2.5 billion for the quarter. The decrease was driven by a reduction in earnings from discontinued operations, partially offset by the increase in earnings from continuing operations, both discussed above. Diluted net earnings per share decreased 4% to $0.93. The difference between the decrease in net earnings and the decrease in the related earnings per share was due to the reduction in weighted average shares outstanding discussed above. Core net earnings per share increased 12% to $0.96. Core net earnings per share represents diluted net earnings per share from continuing operations excluding incremental restructuring charges related to our productivity and cost savings plans.
RESULTS OF OPERATIONS – Nine Months Ended March 31, 2017
The following discussion provides a review of results for the nine months ended March 31, 2017 versus the nine months ended March 31, 2016.
 
Nine Months Ended March 31
Amounts in millions, except per share amounts
2017
 
2016
 
% Chg
Net sales
$
48,979

 
$
49,197

 
 %
Operating income
11,006

 
10,939

 
1
 %
Net earnings from continuing operations
7,992

 
8,019

 
 %
Net earnings from discontinued operations
5,217

 
627

 
N/A

Net earnings attributable to Procter & Gamble
13,111

 
8,557

 
53
 %
Diluted net earnings per common share
4.76

 
3.00

 
59
 %
Diluted net earnings per share from continuing operations
2.87

 
2.78

 
3
 %
Core net earnings per common share
3.07

 
2.88

 
7
 %
 
 
Nine Months Ended March 31
COMPARISONS AS A % OF NET SALES
2017
 
2016
 
Basis Pt Chg
Gross profit
50.5%
 
50.1%
 
40
Selling, general & administrative expense
28.0%
 
27.9%
 
10
Operating income
22.5%
 
22.2%
 
30
Earnings from continuing operations before income taxes
21.1%
 
21.7%
 
(60)
Net earnings from continuing operations
16.3%
 
16.3%
 
Net earnings attributable to Procter & Gamble
26.8%
 
17.4%
 
940

Net Sales
Net sales fiscal year to date were unchanged versus the previous period at $49.0 billion. Unit volume increased 1%. Unfavorable foreign exchange reduced net sales by 2%. Pricing and mix had no net impact on consolidated net sales. Volume increased mid-single digits in Health Care and low single digits in Grooming, Fabric & Home Care and in Baby, Feminine & Family Care. Volume decreased low single digits in Beauty driven by minor brand divestitures. Volume increased low single digits in developed regions and was unchanged in developing regions. Organic sales increased 2% driven by a 2% increase in organic volume.
 
Net Sales Change Drivers 2017 vs. 2016 (Nine Months Ended March 31)*
 
Volume with Acquisitions & Divestitures
 
Volume Excluding Acquisitions & Divestitures
 
Foreign Exchange
 
Price
 
Mix
 
Other**
 
Net Sales Growth
Beauty
(2)%
 
1%
 
(2)%
 
1%
 
1%
 
1%
 
(1)%
Grooming
1%
 
2%
 
(2)%
 
—%
 
(2)%
 
—%
 
(3)%
Health Care
4%
 
5%
 
(2)%
 
1%
 
1%
 
—%
 
4%
Fabric & Home Care
1%
 
2%
 
(2)%
 
(1)%
 
1%
 
—%
 
(1)%
Baby, Feminine & Family Care
2%
 
3%
 
(2)%
 
(1)%
 
(1)%
 
1%
 
(1)%
Total Company
1%
 
2%
 
(2)%
 
—%
 
—%
 
1%
 
—%
* Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
** Other includes the sales mix impact from acquisitions/divestitures and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin increased 40 basis points to 50.5% of net sales for the fiscal year to date period. Gross margin increased primarily due to a 220 basis point positive impact from total manufacturing cost savings (190 basis points net of product and packaging reinvestments) along with minor benefits from lower incremental restructuring charges and increased volume scale leverage. These impacts were partially offset by a 50 basis point negative impact from unfavorable foreign exchange, a 60 basis point decline from unfavorable product mix (primarily between segments caused by the lower relative proportion of sales in Beauty and Grooming, both of which have higher than company-average gross margins, and within segments due to disproportionate growth of lower margin products) and 50 basis points of combined negative impact from higher commodities and other costs.
Total SG&A spending was unchanged at $13.7 billion. SG&A as a percentage of net sales increased 10 basis points to 28.0%. Marketing spending as a percentage of net sales increased 60 basis points due to an increase in advertising and other activities, partially offset by productivity savings. Overhead costs as a percentage of net sales increased 30 basis points due to wage inflation and investments in R&D and sales resources. These impacts were partially offset by an 80 basis point decline in other operating expense due to reduced net foreign exchange transactional costs and a gain on the sale of real estate.
Non-Operating Expenses and Income
Interest expense was $349 million for the fiscal year to date period, a decrease of $80 million versus the prior year period, due to a decrease in weighted average interest rates and a decline in the average debt outstanding. Interest income was $123 million for the fiscal year to date period, a decrease of $12 million versus the prior year period due to a decrease in the average balance of interest-bearing cash and cash equivalents. Other non-operating income/(loss) was $(450) million, a decrease of $488 million, primarily due to a $543 million charge related to early extinguishment of long-term debt incurred in the second fiscal quarter.
Income Taxes on Continuing Operations
The effective tax rate on continuing operations decreased 230 basis points to 22.6%. The rate declined due to excess tax benefits associated with share-based payments due to the adoption of FASB Accounting Standards Update (ASU) 2016-09 Improvements to Employee Share-based Payment Accounting (180 basis points), discrete impacts related to uncertain income tax positions (which netted to 160 basis points in the current year versus 50 basis points in the prior year), the tax impact of the early retirement of certain debts (70 basis points) and the prior year establishment of a valuation allowance on deferred tax assets related to net operating loss carryforwards (80 basis points). These benefits were partially offset by unfavorable geographic mix, primarily due to a higher proportion of U.S. earnings.
Net Earnings from Continuing Operations
Net earnings from continuing operations was unchanged at $8.0 billion for the fiscal year to date period. A reduction in earnings before tax, primarily driven by a $345 million after-tax charge related to the early extinguishment of long-term debt, was offset by the lower effective tax rate. Operating income increased 1% due to the improvement in gross margin discussed above. Foreign exchange impacts reduced net earnings by about $420 million fiscal year to date due to weakening of certain key currencies against the U.S. dollar, primarily the currencies of Argentina, Egypt, Nigeria and the United Kingdom. This impact includes both transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Diluted net earnings per share from continuing operations </